CCNJ and neoplasm: Glutamyl aminopeptidase (ENPEP), casein kinase II subunit α (CK2-α), cyclin J (CCNJ), and multiple epidermal growth factor-like-domains 9 (MEGF9) are additional miR-125b targets that are upregulated in human breast cancer samples and may contribute to tumor progression [53].